This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters to the Editor

Tiagabine Improves Panic and Agoraphobia in Panic Disorder Patients

Peter Zwanzger, Thomas C. Baghai, Cornelius Schule, Christo Minov, Frank Padberg, Hans-Jurgen Moller, and Rainer Rupprecht

Published: August 1, 2001

Article Abstract

Letter to the Editor

Tiagabine Improves Panic and Agoraphobia in Panic Disorder Patients


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 62

Quick Links: Anxiety , Panic Disorder

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Original Research

Sublingual Dexmedetomidine for the Treatment of Acute Agitation in Adults With Schizophrenia or Schizoaffective Disorder: A Randomized Placebo-Controlled Trial

This RCT determined whether a single dose of sublingual dexmedetomidine reduced acute agitation associated with schizophrenia or...

Read More...